LOXL4 and neoplasm: In tumors with WT p53, LOXL4 is somehow silenced at the transcriptional level, and 5-aza-CR derepresses LOXL4, which subsequently leads to the accumulated LOXL4 reactivates compromised p53, resulting to cell death and tumor regression.